Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,148 studies match

clinicaltrialsPublishedShowing 151–200 of 2,148 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06627647	A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC	recruiting	Phase 3	1,160	AstraZenecaINDUSTRY	25	Sep 23, 2026	clinicaltrials
NCT07085767	Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer(OPERA-02)	recruiting	Phase 3	1,000	Olema Pharmaceuticals, Inc.INDUSTRY	23	Sep 23, 2026